“This significant donation will help OMF accelerate and expand current research into ME (Myalgic Encephalomyelitis), CFS (Chronic Fatigue Syndrome) and other chronic complex diseases and to keep fighting for a better future for patients,” said Linda Tannenbaum, founder and president of OMF. Click HERE to read the full article in US News and World Report.